Sex hormone-binding globulin (SHBG) and androgen levels in women with androgenetic alopecia

1987 ◽  
Vol 116 (3_Suppl) ◽  
pp. S144 ◽  
Author(s):  
G. SINNECKER ◽  
E. LUDWIG ◽  
A. KRENZ ◽  
R.P. WILLIG
2011 ◽  
Vol 65 (1) ◽  
pp. 48-53 ◽  
Author(s):  
Salvador Arias-Santiago ◽  
María Teresa Gutiérrez-Salmerón ◽  
Agustín Buendía-Eisman ◽  
María Sierra Girón-Prieto ◽  
Ramón Naranjo-Sintes

1983 ◽  
Vol 109 (3) ◽  
pp. 249-252 ◽  
Author(s):  
R. CIPRIANI ◽  
G. RUZZA ◽  
C. FORESTA ◽  
C. VELLER FORNASA ◽  
A. PESERICO

1986 ◽  
Vol 25 (5) ◽  
pp. 597-605 ◽  
Author(s):  
K. L. FORBES ◽  
M. DOWSETT ◽  
GILLIAN L. ROSE ◽  
JOANNE E. MUDGE ◽  
S. L. JEFFCOATE

1982 ◽  
Vol 101 (2) ◽  
pp. 248-253 ◽  
Author(s):  
Viveca Odlind ◽  
Kerstin Elamsson ◽  
Doris E. Englund ◽  
Arne Victor ◽  
Elof D. B. Johansson

Abstract. Sex hormone binding globulin (SHBG) levels were studied for possible effects of oestradiol-17β on SHBG. No change in SHBG plasma was recorded during normal menstrual cycles or during treatment with oestradiol-17β to menopausal women. However, gonadotrophin treatment to amenorrhoeic women to induce ovulation resulted in high oestradiol concentrations and a pronounced increase in SHBG was found during the luteal phase of these cycles. A marked increase of SHBG was also recorded in a woman with pronounced fluctuations of oestradiol during treatment with levonorgestrel sc implants for contraception. In conclusion, effects on SHBG were only found when extraordinarily high levels of plasma oestradiol were recorded.


Sign in / Sign up

Export Citation Format

Share Document